Printer Friendly

BIOMERICA SIGNS SALES AGREEMENT WITH INTERNATIONAL MEDICAL COMPANY

 NEWPORT BEACH, Calif., Jan. 21 /PRNewswire/ -- Biomerica Inc. (NASDAQ: BMRA) has announced that it has entered into a marketing agreement with Bio-Rad Laboratories Inc. for the distribution of its ulcer test in the Far East. The agreement excludes Japan since Biomerica has already signed an agreement with a notable Japanese firm for distribution of the product in Japan.
 As a result of these agreements, Biomerica is already experiencing an increase in sales for the gastritis and peptic ulcer test (GAP). Orders are coming from China, Italy, Japan and other parts of the world. The GAP is approved by both the FDA and the Japanese Ministry of Health.
 Biomerica anticipates the distribution of more of its products through these types of established channels.
 Biomerica is a medical company engaged in the development, manufacturing and marketing of advanced medical diagnostic products including home self-testing.
 -0- 1/21/93
 /CONTACT: Joseph Irani, president of Biomerica, 714-645-2111/
 (BMRA)


CO: Biomerica Inc. ST: California IN: MTC SU:

JL -- LA012 -- 7408 01/21/93 12:22 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 21, 1993
Words:171
Previous Article:INTERNATIONAL CABLECASTING TECHNOLOGIES (ICT) EUROPE ANNOUNCES AFFILIATION AND DISTRIBUTION AGREEMENTS ACROSS EUROPE
Next Article:THE VONS COMPANIES SENDS AID TO FLOOD VICTIMS IN TIJUANA TODAY
Topics:


Related Articles
Biomerica Signs New Egyptian Distributor.
Biomerica Reports Year-End Financial Results.
Biomerica Announces Increase in Sales in First Quarter Results.
Biomerica Signs Agreements to Sell Two Minute Home Test for Colorectal Disease In Brazil, United Kingdom, and Canada.
Biomerica to Produce Diagnostic Products For Worldwide Distribution by ICN Pharmaceuticals.
Biomerica Sales Up 11.5 Percent in FY 2001; Diagnostic Division Sales Increase Over 27%.
Biomerica Announces Agreement to Purchase Remaining Interest In Lancer Orthodontics, Inc.
Biomerica Signs Contract to Develop New Food Allergy Test for Leading Japanese Medical Company.
Biomerica Signs Contract to Develop New Food Allergy Test For Leading Japanese Medical Company.
Biomerica Announces 8.4 Percent Sales Increase in First Quarter.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters